A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines - Nature
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines Nature
A glycan-based adjuvant expands the breadth and duration of protection of mRNA-based vaccines Nature
COVID-19 mRNA vaccines: a prospective outlook from technological innovation to clinical practice Frontiers
Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes Science | AAAS
Vaccine symposium airs multiple ideas for accelerating preventive immunology Stanford Medicine
Researchers Uncover How Obesity Impairs Vaccine Response The American Association of Immunologists
Rapid boosting increases germinal center responses to sequential vaccines Nature
Opinion | I Grew Up Unvaccinated. Now I’m an Immunologist. The New York Times
Vaccines: protecting more than you think British Society for Immunology
Editorial: Innovative vaccine development strategies for parasitic diseases Frontiers
Why Vaccines Are Especially Important If You Have Asthma or Allergies American College of Allergy Asthma and Immunology
New Horizons for Immunology and Vaccine Research at Cincinnati Children’s Research Horizons
mRNA-based influenza vaccine expands the B cell response breadth in humans Nature
mRNA: the vaccine revolution British Society for Immunology
GenIV vaccines: bridging innovation to equity in neglected tropical diseases Frontiers
Editorial: Towards the rapid and systematic assessment of vaccine technologies Frontiers
Programming the immunological properties of mRNA vaccines for cancer Nature
RSV vaccine development: advances and fusion protein-focused strategies Frontiers
Cancer vaccines as enablers of immunotherapy Nature
Editorial: Helminthosis: immuno-pathology and anthelmintic vaccines Frontiers
A guide to vaccinology: from basic principles to new developments Nature
Distinct baseline immune characteristics associated with responses to conjugated and unconjugated pneumococcal polysaccharide vaccines in older adults Nature
Mucosal unadjuvanted booster vaccines elicit local IgA responses by conversion of pre-existing immunity in mice Nature
Eliciting antitumor immunity via therapeutic cancer vaccines Nature
COVID-19 vaccines: modes of immune activation and future challenges Nature
Editorial: Systems immunology to advance vaccine development Frontiers
Glycemic control and vaccine response: the role of mucosal immunity after vaccination in diabetic patients Frontiers
Viral targets for vaccines against COVID-19 Nature
Blood test can predict how long vaccine immunity will last, Stanford Medicine-led study shows Stanford Medicine
Designing Vaccines for the Twenty-First Century Society Frontiers
Immunological considerations for COVID-19 vaccine strategies Nature
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination Nature
Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants Science | AAAS
Potential of mRNA-based vaccines for the control of tick-borne pathogens in one health perspective Frontiers
Emerging Concepts and Technologies in Vaccine Development Frontiers
Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses Nature
Mucosal vaccines — fortifying the frontiers Nature
Vaccination in pregnancy to protect the newborn Nature
Precision Vaccine Development: Cues From Natural Immunity Frontiers
Technological breakthroughs and advancements in the application of mRNA vaccines: a comprehensive exploration and future prospects Frontiers
Immunological factors linked to geographical variation in vaccine responses Nature